ProPhase Labs, Inc.
PRPH
$0.3396
-$0.0107-3.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.36M | -6.59M | -6.15M | -6.27M | -8.75M |
| Total Depreciation and Amortization | 613.00K | 2.51M | 1.73M | 1.80M | 1.71M |
| Total Amortization of Deferred Charges | 485.00K | 619.00K | 235.00K | 146.00K | 35.00K |
| Total Other Non-Cash Items | 9.84M | 660.00K | 771.00K | 1.54M | 1.36M |
| Change in Net Operating Assets | 19.85M | -1.23M | -1.40M | -2.33M | 4.89M |
| Cash from Operations | -3.57M | -4.03M | -4.82M | -5.12M | -753.00K |
| Capital Expenditure | 235.00K | -176.00K | -26.00K | -939.00K | -239.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 79.00K | 150.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -275.00K | 0.00 | 0.00 | 3.37M | -1.07M |
| Cash from Investing | -40.00K | -97.00K | 124.00K | 2.44M | -1.26M |
| Total Debt Issued | 1.53M | 4.47M | 1.41M | 2.46M | 0.00 |
| Total Debt Repaid | -1.74M | -1.61M | -709.00K | -189.00K | -- |
| Issuance of Common Stock | 2.97M | 0.00 | 4.62M | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.74M | 2.86M | 5.32M | 2.27M | 2.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.00K | -1.27M | 629.00K | -413.00K | 907.00K |